transmission-blocking.

Show results for

Unknown (1213)
Genomics (65)
Proteomics (34)
Transcriptomics (32)
Other (1)
Metabolomics (1)

Organisms

Andropogon gerardi (23)
Bacteria (23)
Canis lupus familiaris (23)
Chromatiales bacterium OalgGamma1 (23)
Clavibacter nebraskensis NCPPB 2581 (23)
Cnidaria (23)
Ensifer adhaerens (23)
Fasciola (23)
Human alphaherpesvirus 1 strain 17 (23)
Plasmodium falciparum (14)
Mus musculus (4)
Anopheles gambiae (3)
Staphylococcus aureus (3)
Aedes aegypti (2)
Solanum lycopersicum (2)
Plasmodium berghei (2)
Homo sapiens (2)
Vitis vinifera (1)
Drosophila melanogaster (1)
Danio rerio (1)
Glossina palpalis (1)
Yersinia pestis CO92 (1)
Yersinia pestis KIM10+ (1)
Yersinia pseudotuberculosis (1)
Yersinia pestis (1)
Plasmodium falciparum 3D7 (1)
Macaca mulatta (1)
Rattus norvegicus (1)
wastewater metagenome (1)
Plasmodium (1)

Organisms

Plasmodium falciparum (12)
Anopheles dirus (3)
Plasmodium berghei (2)
Mus musculus (2)
Homo sapiens (2)
Glossina palpalis (1)
Rhipicephalus sanguineus (1)
Chlamydomonas urium (1)
Rhipicephalus bursa (1)
Plasmodium falciparum 3D7 (1)
Macaca mulatta (1)
Ixodes ricinus (1)
Anopheles gambiae (1)
Aedes aegypti (1)
Solanum lycopersicum (1)
Staphylococcus aureus (1)
Klebsiella pneumoniae (1)
Plasmodium yoelii (1)

Repository

ENA (61)
geo (24)
pride (23)
biostudies-arrayexpress (13)
MassIVE (5)
iProX (3)
PAXDB (2)
GNPS (1)
jPOST (1)

Tissue

Cell culture (3)
Permanent cell line cell (2)
Saliva (2)
Blood (1)
Blood cell (1)
Blood plasma (1)
Brain (1)
Erythrocyte (1)
Fat body (1)
Fibroblast (1)
Gametocyte (1)
Midgut (1)
Muscle (1)
Ookinete (1)
Salivary gland (1)
Salivary gland cell (1)
Skin (1)

Disease

Malaria (4)
Disease free (2)
Plasmodium falciparum malaria (2)

Technology Type

Mass Spectrometry (23)
Shotgun proteomics (11)
Bottom-up proteomics (8)
Affinity purification coupled with mass spectrometry proteomics (5)
Data-dependent acquisition (5)
Gel-based experiment (2)
Chemical cross-linking coupled with mass spectrometry proteomics (1)
Data-independent acquisition (1)

Instrument Platform

LTQ Orbitrap XL (2)
Xevo G2 Q-Tof (2)
LTQ XL (2)
Illumina HiSeq 3000 (1)
LTQ XL ETD (1)
Orbitrap Fusion (1)

Publication Date

2021 (12)
2025 (10)
2014 (5)
2019 (5)
2026 (5)
2016 (4)
2024 (4)
2022 (4)
2023 (3)
2018 (3)
2017 (3)
2013 (2)
2012 (2)
2011 (2)
2010 (2)
2020 (2)
2008 (1)
2004 (1)
2007 (1)
2005 (1)

UNIPROT ID/AC

5833.MAL13P1.267 (2)
5833.MAL13P1.269 (2)
5833.MAL13P1.325 (2)
5833.MAL13P1.334 (2)
5833.MAL7P1.78 (2)
5833.MAL8P1.208 (2)
5833.MAL8P1.320 (2)
5833.PF11_0033 (2)
5833.PF11_0263 (2)
5833.PF11_0512 (2)
5833.PF13_0305 (2)
5833.PF13_0321 (2)
5833.PF14_0001 (2)
5833.PF14_0009 (2)
5833.PF14_0173 (2)
5833.PF14_0734 (2)
5833.PF14_0751 (2)
5833.PF14_0756 (2)
5833.PF14_0759 (2)
5833.PFA0105w (2)
5833.PFA0120c (2)
5833.PFA0705c (2)
5833.PFB0050c (2)
5833.PFB0280w (2)
5833.PFB0925w (2)
5833.PFB0946c (2)
5833.PFC1011c (2)
5833.PFC1075w (2)
5833.PFD0075w (2)
5833.PFD0100c (2)

First Public Date

2025 (11)
2026 (8)
2024 (6)
2021 (6)
2023 (5)
2022 (5)
2017 (5)
2019 (4)
2020 (3)
2016 (3)
2014 (3)
2018 (1)
2015 (1)

Classification

protozoa (16)
bacteria (2)

Study type

Transcription profiling by array (9)
RNA-seq of coding RNA (2)
Unknown experiment type (1)
Animal - High-throughput sequencing (1)

Release Date

2022 (140)
2021 (126)
2023 (122)
2020 (107)
2025 (95)
2024 (95)
2018 (84)
2019 (81)
2017 (73)
2016 (61)
2014 (48)
2015 (48)
2013 (36)
2010 (23)
2012 (19)
2026 (14)
2011 (13)
2008 (8)
2009 (8)
2006 (5)
2004 (4)
2005 (4)
2007 (3)
1999 (3)
2002 (2)
2003 (1)
2001 (1)
2000 (1)
1998 (1)

Lab affiliation

Integrative Parasitology, Centre for Infectious Diseases, University Hospital Heidelberg, Heidelberg University Medical Faculty; Heidelberg, Germany (2)
Chemical Biology & Proteomics, Biogen (1)
Core Facility for Mass Spectrometry and Proteomics, Center for Molecular Biology of Heidelberg University (ZMBH) (1)
Departamento de Parasitologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil (1)
Department of Biological Sciences, Seoul National University, Seoul 08826, Republic of Korea (1)
Department of Burns and Reconstructive Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China. (1)
Department of Medical Microbiology, Radboud University Medical Center, The Netherlands (1)
Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Switzerland (1)
Division of Cell and Molecular Biology, Imperial College London, UK (1)
EMBL Hamburg Germany (1)
Emerging Pathogens Institute, University of Florida (1)
Institute of Bioinformatics, International Technology Park, Bangalore, Karnataka 560066, India (1)
Italian NationalInstitute of Health (1)
London School of Hygine and Tropical Medicine (1)
National Institute of Malaria Research, Field Station, Goa 403001, India (1)
Parasitology, University of São Paulo/Institute of Biomedical Sciences, Brazil (1)
RG Neurohomeostasis, Department of Psychiatry and Psychotherapy, University Hospital Bonn, Germany (1)
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. (1)
School of Life Sciences, Queens Medical Centre, University of Nottingham, Nottingham, NG7 2UH (1)
School of Life Sciences, University of Nottingham, Nottingham, UK (1)
Sorbonne Université, INSERM, UMS PASS, Plateforme Post-génomique de la Pitié Salpêtrière (P3S), 75013, Paris, France (1)
The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3052, Australia (1)

Previous page
1 / 135
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 135
Next page

Sort by:

Relevance

Page size

Seroprevalence of antibodies to <i>Plasmodium falciparum</i> transmission-blocking target proteins Pfs230D1M and Pfs48/45 in Tanzanian populations of diverse malaria transmission intensity.

Not available

S-EPMC12460233 | biostudies-literature

The nitrobenzoxadiazole derivative NBDHEX behaves as Plasmodium falciparum gametocyte selective inhibitor with malaria parasite transmission blocking activity

This work describes the activity of 6-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)thio)hexan-1-ol (NBDHEX) and of its newly identified carboxylic acid metabolite on human malaria parasite Plasmodium falciparum. NBDHEX has been previously identified as a potent cytotoxic agent against murine and human can...

ORGANISM(S): Homo sapiens (Human) Plasmodium falciparum

2022-03-03 | PXD030336 | Pride